How much did Sightera Biosciences raise?

Sightera Biosciences raised €3M at Pre-Seed, announced 17 July 2026.

Who founded Sightera Biosciences?

Hendrik Vercammen is Co-founder & CEO of Sightera Biosciences.

What does Sightera Biosciences do?

Sightera Biosciences operates in HealthTech and is based in Belgium.

FundedStartupsDaily / HealthTech / Sightera Biosciences

Sightera Biosciences raises €3M

Sightera Biosciences announced a Pre-Seed round of €3M on 17 July 2026. The company operates in HealthTech and is based in Belgium. It was founded by Hendrik Vercammen, Co-founder & CEO.

Raised

€3M

Stage

Pre-Seed

Industry

HealthTech

Country

Belgium

Founder

Hendrik Vercammen

Co-founder & CEO, Sightera Biosciences

LinkedIn profile sightera.bio

Outreach angles

-Hendrik trained in pharmaceutical sciences at the University of Antwerp with drug development work in the US.
-He co-founded Sightera with Maxim Le Compte, Lars Vanlommel, and Christophe Deben in early 2025.
-The €3M pre-seed funds an AI drug discovery platform that learns from extreme patient biology, targeting oncology and fibrosis.